Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ·Healthcare·Biotechnology
$24.78
+1.41%
Mkt Cap $1.54B
Analyst Ratings
Buy
11
Hold
5
Sell
0
Price Target (19 analysts)
$41.50
Range $25.00 – $62.00
Implied Upside
+67.5%
Consensus $41.50 vs current $24.78
NASDAQ·Healthcare·Biotechnology
$24.78
+1.41%
Mkt Cap $1.54B
Buy
11
Hold
5
Sell
0
Price Target (19 analysts)
$41.50
Range $25.00 – $62.00
+67.5%
Consensus $41.50 vs current $24.78